Tag: COVID-19 vaccine candidate
IDT in talks to manufacture Australia’s first COVID-19 vaccine candidate
Melbourne-based pharmaceutical manufacturer IDT Australia is locked in discussions with the Victorian Government, mRNA Victoria and the Monash Institute of Pharmaceutical Sciences (MIPS) to...
Australia to purchase 51 million doses of COVID-19 vaccine from Novavax
American vaccine development company Novavax, Inc. has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, its...
WACKER to manufacture CureVac’s COVID-19 vaccine candidate in Amsterdam
German biotech firm CureVac and Wacker Chemie AG have signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV.
CureVac is a biopharmaceutical...
CSL to manufacture and supply two COVID-19 vaccine candidates for Australia
The Australian Government has signed an agreement with CSL under which the global biotech company will supply 51 million doses of the University of...
Featured Article
AMCA Impact Study highlights AI’s role in improving HVAC safety compliance
A new AMCA Impact Study has highlighted the growing challenge of helping HVAC contractors access reliable safety and compliance information quickly, particularly for small and medium-sized businesses operating in Australia's highly regulated construction environment.
